LOGIN  |  REGISTER
Cue Biopharma

Stryker (NYSE: SYK) Stock Quote

Last Trade: US$334.91 7.23 2.21
Volume: 1,329,664
5-Day Change: -1.24%
YTD Change: 11.84%
Market Cap: US$127.420B

Latest News From Stryker

Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2024, that ended March... Read More
Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at... Read More
MAHWAH, N.J. , USA , March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix. "The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence," said Katherine Truppi , President of... Read More
MAHWAH, N.J. , Feb. 13, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technology, showcases its commitment to innovation and technological advancement in Joint Replacement with the introduction of Triathlon ® Hinge as well as the continued evolution of Mako SmartRobotics™ at this year's American Academy of Orthopaedic Surgeons' (AAOS) 2024 Annual Meeting in San Francisco . Triathlon Hinge: Building on... Read More
Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and,... Read More
Portage, Michigan, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 1:45 p.m. Eastern Time. A... Read More
Stryker’s Footprint and Infinity Total Ankle System will be featured at the American College of Foot and Ankle Surgeons Annual Meeting PORTAGE, Mich. / Jan 31, 2024 / Business Wire / Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system... Read More
Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billion Organic net sales increased 11.4% Reported operating income margin of 21.6% Adjusted operating income margin (1) increased 60 bps to 27.2% Reported EPS increased 102.7% to $2.98 Adjusted EPS (1) increased... Read More
HealthStocksHub
Stryker’s Gamma4 Hip Fracture Nailing System Used in Over 19,000 Cases Since Launch KALAMAZOO, Mich. / Jan 17, 2024 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technologies companies, has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw,... Read More
HealthStocksHub
Blueprint Mixed Reality Guidance System for shoulder arthroplasty offers surgeons a new tool to execute their pre-operative plan using 3D imaging and operate with more precision and consistency KALAMAZOO, Mich. / Jan 10, 2024 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today... Read More
Portage, Michigan, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023. “We are excited to surpass this major milestone and to share with our employees as we have our kick-off meetings for 2024,” said Kevin Lobo, Chair and Chief Executive Officer. “This means that we are positively impacting... Read More
Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year 2023, that ended... Read More
MAHWAH, N.J., USA , Dec. 18, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, announced today that it has executed a binding offer to Menix to acquire SERF SAS, a France -based joint replacement company. With a legacy of over 50 years, SERF SAS is recognized by healthcare professionals worldwide for its innovations in hip implants, including the invention of the original Dual... Read More
Kalamazoo, Michigan, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that its Board of Directors intends to nominate Rachel Ruggeri for election to the Company’s Board of Directors at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024. Ms. Rachel Ruggeri has over 25 years of global finance leadership experience and serves as the executive vice president and chief... Read More
Kalamazoo, Michigan, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stand for re-election at Stryker's 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024. Dr. Datar is the Dean of the Harvard Business School and George F. Baker Professor of Business Administration. He... Read More
Kalamazoo, Michigan, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable January 31, 2024 to shareholders of record at the close of business on December 29, 2023, representing an increase of 6.7% versus the prior year and previous quarter. “We continue to deliver strong growth and solid financial performance, and aligning with... Read More
Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 billion Organic net sales increased 9.2% Reported operating income margin of 19.0% Adjusted operating income margin (1) increased 110 bps to 23.4% Reported EPS decreased 15.9% to $1.80 Adjusted EPS (1) increased 16.0% to $2.46 Third... Read More
Kalamazoo, Michigan, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at the Kimpton EPIC Hotel in Miami, Florida. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 1:20 p.m. Eastern Time. A simultaneous... Read More
Stryker to showcase Q Guidance System with spine and cranial applications at NASS Annual Meeting LEESBURG, Va. / Oct 12, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that its Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases. The Q Guidance System for both spine and... Read More
Kalamazoo, Michigan, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Wednesday, November 8, 2023, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at Stryker - Events & Presentations . An archive of the webcast will also be available on the company's website two hours... Read More
Kalamazoo, Michigan, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s third quarter of fiscal year 2023, that ended... Read More
HealthStocksHub
Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J. , Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10 th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013,... Read More
HealthStocksHub
Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting KALAMAZOO, Mich. / Sep 19, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep ® MIS Lapidus, a new internal fixation system intended... Read More
Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities SAN JOSE, California , USA , Sept. 14, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, today unveiled the next-generation of minimally invasive surgical cameras: the 1788 platform. The fully enhanced... Read More
Pangea to offer a comprehensive and versatile portfolio, providing variable-angle plating for a variety of patient populations KALAMAZOO, Mich. / Sep 12, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration. “FDA clearance... Read More
Kalamazoo, Michigan, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 3:00 p.m. Eastern Time. A simultaneous webcast and replay of the Company's... Read More
"Scan. Plan. Mako Can." spotlights and differentiates Stryker's Mako SmartRobotics™ for partial knee, total knee and total hip replacement surgery MAHWAH, N.J. , Aug. 4, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's largest medical technology companies, announced the launch of a nationwide, direct-to-patient marketing campaign, "Scan. Plan. Mako Can." Through this campaign, Stryker aims to continue to drive... Read More
Kalamazoo, Michigan, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billion Organic net sales increased 11.9% Reported operating income margin of 19.3% Adjusted operating income margin (1) increased 60 bps to 24.3% Reported EPS increased 12.2% to $1.93 Adjusted EPS (1) increased 12.9% to $2.54... Read More
Kalamazoo, Michigan, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable October 31, 2023 to shareholders of record at the close of business on September 29, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies... Read More
HealthStocksHub
Stryker’s navigation system offers surgeons a comprehensive planning and guidance solution for complex cranial procedures. LEESBURG, Va. / Jul 11, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software... Read More
HealthStocksHub
Ortho Q Guidance system with Ortho Guidance software offers state-of-the-art workflow KALAMAZOO, Michigan , USA , July 6, 2023 /PRNewswire/ -- Stryker (NYSE:SYK) announced the launch of its Ortho Q Guidance system, the only fully autonomous system in the industry, easily controlled by the surgeon from the sterile field. The... Read More
Kalamazoo, Michigan, June 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter of fiscal year 2023, which ends on... Read More
HealthStocksHub
Technology provides groundbreaking planning and guidance capabilities LEESBURG, Va. / May 24, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The... Read More
Kalamazoo, Michigan, May 10, 2023 (GLOBE NEWSWIRE) Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together... Read More
KALAMAZOO, Michigan , USA , May 2, 2023 /PRNewswire/ -- Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular's CE Marked products,... Read More
Kalamazoo, Michigan, May 01, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results Reported net sales increased 11.8% to $4.8 billion Organic net sales increased 13.6% Reported operating income margin of 15.4% Adjusted operating income margin ( 1) contracted 70 bps to 21.1% Reported EPS increased 83.3% to $1.54 Adjusted EPS ( 1) increased 8.6% to $2.14... Read More
Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2023, which ends on... Read More
HealthStocksHub
First clinical use of Stryker’s Tornier Pyrocarbon Humeral Head completed at Denver Surgery Center in Colorado DENVER / Mar 30, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery... Read More
Kalamazoo, Michigan, March 28, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2023 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 10, 2023 – 9:00 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at... Read More
HealthStocksHub
KALAMAZOO, Michigan , USA, March 2, 2023 /PRNewswire/ -- Stryker (NYSE:SYK) announced the launch of its CD NXT System, the latest innovation in the company's power tools. This patented technology provides real-time depth measurement as the surgeon drills, allowing for fast, accurate, consistent digital depth measurement across... Read More
KALAMAZOO, Mich. / Feb 17, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative guidance system designed to support cranial surgeries. Recently launched in September... Read More
Kalamazoo Michigan,, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable April 28, 2023 to shareholders of record at the close of business on March 31, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and,... Read More
Kalamazoo, Michigan , Jan. 31, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billion Organic net sales increased 13.2% Reported operating income margin of 15.6% Adjusted operating income margin (1) contracted 70 bps to 26.6% Reported EPS decreased 15.0% to $1.47 Adjusted EPS (1) increased... Read More
Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the... Read More
Compass Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB